| 2018-01-22 | Sale | Cardinal Health, Inc. CAH | Chief Executive Officer | 37,172 0.0118% | $73.90 | $2.75M | -26.21% | |
| 2014-09-04 | Sale | Cardinal Health, Inc. CAH | CEO, Pharmaceutical Segment | 100,432 0.0238% | $58.02 | $5.83M | +15.22% | |
| 2014-08-18 | Sale | Cardinal Health, Inc. CAH | CEO, Pharmaceutical Segment | 13,666 0.0041% | $72.06 | $984,772 | +18.53% | |
| 2014-02-11 | Sale | Cardinal Health, Inc. CAH | CEO, Pharmaceutical Segment | 630,990 0.1803% | $67.57 | $42.64M | +5.16% | |
| 2014-02-10 | Sale | Cardinal Health, Inc. CAH | CEO, Pharmaceutical Segment | 147,000 0.0306% | $47.15 | $6.93M | +9.7% | |
| 2013-05-22 | Sale | Cardinal Health, Inc. CAH | CEO, Pharmaceutical Segment | 72 <0.0001% | $47.52 | $3,421 | +36.81% | |
| 2013-01-23 | Sale | Cardinal Health, Inc. CAH | CEO, Pharmaceutical Segment | 116,724 0.0341% | $44.95 | $5.25M | +12.68% | |
| 2011-10-27 | Sale | Cardinal Health, Inc. CAH | CEO, Pharmaceutical Segment | 82,328 0.0239% | $44.95 | $3.7M | -6.89% | |
| 2011-10-26 | Sale | Cardinal Health, Inc. CAH | CEO, Pharmaceutical Segment | 4,000 0.0009% | $36.12 | $144,480 | -5.08% | |
| 2011-07-01 | Sale | Cardinal Health, Inc. CAH | CEO, Pharmaceutical Segment | 20,286 0.005% | $39.14 | $793,994 | -8.92% | |
| 2011-05-05 | Sale | Cardinal Health, Inc. CAH | CEO, Pharmaceutical Segment | 20,286 0.005% | $38.64 | $783,851 | -4.38% | |
| 2011-04-27 | Sale | Cardinal Health, Inc. CAH | CEO, Pharmaceutical Segment | 20,286 0.005% | $38.14 | $773,708 | -3.23% | |
| 2011-04-21 | Sale | Cardinal Health, Inc. CAH | CEO, Pharmaceutical Segment | 17,120 0.0049% | $42.95 | $735,304 | -0.6% | |
| 2011-03-18 | Sale | Cardinal Health, Inc. CAH | CEO, Pharmaceutical Segment | 354 <0.0001% | $31.93 | $11,301 | +5.59% | |
| 2011-02-07 | Sale | Cardinal Health, Inc. CAH | CEO, Pharmaceutical Segment | 175,088 0.0501% | $41.71 | $7.3M | +2.03% | |
| 2010-12-03 | Sale | Cardinal Health, Inc. CAH | CEO | 633 0.0002% | $37.29 | $23,605 | +13.88% |